Replies to post #297138 on Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

I thought you made your case very succinctly and point by point. Well done.

Though we are at a great place now, we have had to go thru very troubling times and most of us have asked ourselves the same questions you just put forth.

I thought we were in great shape w/ the success of the IBD pill and the expected partnership for OM (though the time taken to bring about a partner mind numbing)and the K pill seems just about ready when funds become available.

But it is ironic that the event that seems to make IPIX success very probable was handed to us, not something we planned for or worked to attain. Too bad it took a world catastrophe to bring it about.

I didn't like having to hear what you had to say, but I can't fault the points you made.

Bottom line seems to be that we longs have had a long and rocky ride and deserve to now reap some rewards.

At this point in time I think the greatest thanks I should give is to the ones that have been so intent on compressing our share price. People can have whatever idea they want as to the reasons for it, I just look at the trading pattern over YEARS and can see something completely amiss and criminal has been dominating the scene. Like you, I have now raised my holdings to where I don't even need $1.50 to live my remaining days in total luxury (remember I am 70). I believe we blow right past that in the next few weeks.

[TheDane]

Yawn. Who cares? You’re still invested? Count yourself lucky.

[frenchbroad]

Certaine I will proffer no arguing that M. Ehrlich could have been more seeing of the futur and make different decisions. And certainment the buying of Brilacin for 5 millions was brillante. Many personnes made the mistake of things as they learn and try to be more wise. M. Edison and Pastuer and Jobs and Tesla made mistake and managing was difficult. I do not say that M. Ehrlich is one of personnes like this but I believe that he will bring good value for Brilacin and Kevetrin after.

[steelyeye]

I don't... what's funny is when anyone makes consistently negatives calls about IPIX, its very easy to cherry pick accurate correlations.

With all the complaints about Leo's management, managing to double one's share count in the last 8 weeks doesn't sound like playing roulette or hoping to get lucky.

I give TIAB credit...

[To infinity and beyond!]

Take B OM trial as your example. All the anti inflammatory jazz shoulda helped and then there was the Sonis data that predicted success- but B OM results did not fly.

It's all well and good if B has a lot potential for coronavirus and it will be wonderful if it works. The 16 hour data points were not impressive but who cares, good enough to get a foot in the door.

But what next? What about April? Results so good that NOTHING happened the whole month! The very excited RBL staff, sitting on the wonder drug did nothing.

But who cares, the next round of testing started May 1, anyway. (So what about initial data, good enough to carry on, fine by me)

And we will find out how B did- if and when Leo bothers to inform us shareholders.
Initial culture data was very likely done 10 days ago- but we are not informed.

unfortunately I think Leo's history of burial of bad news is now the key to seeing why we have not been informed of RBL tests this month.

My attacks on P2b and B OM data were simple and obvious though glad to take any credit due. Most of the problem was deliberate obfuscation of data by IP to hype results- very sad.